X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/fallout-quantum-genomics-phase-3-fail-claims-top-executives-biotech-searches-future
https://www.globenewswire.com/news-release/2021/05/19/2232760/0/en/Quantum-Genomics-Announces-the-Publication-of-New-Scientific-Article-in-Biomedicine-Pharmacotherapy-Which-Further-Strengthens-its-Phase-III-Development-Plan-in-Difficult-to-Treat-a.html
https://www.globenewswire.com/news-release/2021/04/21/2213820/0/en/Quantum-Genomics-Will-Present-Top-line-Results-From-its-QUORUM-Study-of-Firibastat-in-Heart-Failure-Post-Myocardial-Infarction-at-the-European-Society-of-Cardiology-ESC-Meeting.html#:~:text=PARIS%2C%20April%2021%2C%202021%20(,top%2Dline%20results%20from%20its
https://www.globenewswire.com/news-release/2021/04/20/2212887/0/en/Quantum-Genomics-Announces-the-End-of-its-Collaboration-with-Qilu-for-the-Development-and-Commercialization-of-Firibastat-in-China.html
https://www.globenewswire.com/news-release/2021/01/18/2160169/0/en/Quantum-Genomics-Launches-Phase-III-Pivotal-REFRESH-Study-in-Difficult-to-treat-Resistant-Hypertension-with-Once-a-day-Formulation-of-Firibastat.html
https://www.globenewswire.com/news-release/2021/01/18/2160169/0/en/Quantum-Genomics-Launches-Phase-III-Pivotal-REFRESH-Study-in-Difficult-to-treat-Resistant-Hypertension-with-Once-a-day-Formulation-of-Firibastat.html
https://www.globenewswire.com/news-release/2020/12/15/2145000/0/en/Quantum-Genomics-Enters-into-Exclusive-Licensing-and-Collaboration-Agreement-with-Faran.html#:~:text=PARIS%20and%20NEW%20YORK%2C%20Dec,has%20entered%20into%20an%20exclusive
https://www.globenewswire.com/news-release/2020/10/19/2110133/0/en/Quantum-Genomics-Enters-into-Exclusive-Licensing-and-Collaboration-Agreement-with-Qilu-Pharmaceutical.html#:~:text=PARIS%20and%20NEW%20YORK%2C%20Oct,has%20entered%20into%20an%20exclusive
Market Place
Share 
